GUD — Knight Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual balance sheet for Knight Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	163	191	158	163	114
Net Total Accounts Receivable
Net Total Receivables	67.4	110	110	123	138
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	305	396	365	397	395
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29.9	22.6	17.9	20	21.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	992	1,055	945	964	1,046
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	105	141	114	111	165
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	150	229	199	169	279
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	842	826	747	795	767
Total Liabilities & Shareholders' Equity	992	1,055	945	964	1,046
Total Common Shares Outstanding